While our results clearly and convincingly demonstrate that CMLD-2 is effective against lung cancer cells, the question of how CMLD-2 targets HuR and exhibits selectivity to cancer cells compared to normal cells, when HuR is expressed in both cell types, is unclear. This evidence concerns the gene ELAVL1 and cancer.